223786-59-2Relevant academic research and scientific papers
Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
-
, (2008/06/13)
The use of inhibitors of GSK-3 useful for treating glaucoma is disclosed.
Use of 2,4-diaminothiazole derivatives
-
, (2008/06/13)
2,4-Diaminothiazole derivatives which inhibit GSK-3 (glycogen synthase kinase-3) and which are useful for the treatment and/or prevention disorders and diseases wherein an inhibition of GSK-3 is beneficial, especially especially Alzheimer's disease, bipolar disorder, IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity.
